Skip to content
Search

Latest Stories

Obesity drug could reduce heart attack risk, study finds

The trial, involving 17,604 patients, evaluated Wegovy not for weight loss but for its heart-protective benefits in overweight and obese individuals.

Obesity drug could reduce heart attack risk, study finds

An obesity drug has been found to decrease the risk of heart attacks, strokes, or heart failure in obese individuals regardless of the amount of weight they lose while on the medication, according to researchers.

The study of the drug, Wegovy, revealed that participants maintained significant weight loss over four years, with fewer serious adverse events compared to those given placebo treatment, reported Sky News.


These findings may prompt UK health authorities, which currently limit treatment to two years, to reconsider their policies.

The Danish drugmaker presented the new long-term data on Tuesday at the European Congress on Obesity in Venice, Italy, in a new analysis from a large study for which substantial results had been published last year, reported Reuters.

On average, participants lost 10.2 per cent of their body weight and 7.7 cm from their waist size after four years.

Even individuals with mild obesity or modest weight loss experienced cardiovascular benefits, suggesting potential broader effects of the treatment beyond fat reduction.

The study, led by Professor John Deanfield of University College London (UCL), utilised data from the Select trial conducted by Wegovy manufacturer Novo Nordisk.

Semaglutide, the active ingredient in Wegovy, belongs to a class of GLP-1 drugs that suppress appetite, aiding in calorie reduction.

The trial, involving 17,604 patients, evaluated Wegovy not for weight loss but for its heart-protective benefits in overweight and obese individuals with preexisting heart disease but without diabetes. Participants were not required to monitor diet and exercise as it was not focused on obesity, Reuters reported.

Around 17 per cent of trial participants discontinued Wegovy use due to side effects, primarily nausea, according to Novo's analysis.

Patients in the Select trial lost an average of nearly 10 per cent of their total body weight after 65 weeks on Wegovy. This weight loss was maintained year on year, reaching 10.2 per cent after approximately four years, as reported by the company.

Another analysis by Novo, also released on Tuesday, demonstrated that Wegovy's heart-protective benefits were consistent regardless of patients' initial weight or the amount of weight they lost on the drug.

"We now also understand that while we know that body weight loss is important, it's not the only thing driving the cardiovascular benefit of semaglutide treatment," Lange told Reuters in an interview.

The Select study revealed that Wegovy reduced the risk of major cardiovascular events such as strokes by 20 per cent in overweight or obese individuals with a history of heart disease. This news led to a 13 per cent surge in Novo shares to record highs upon its release in August.

Novo continues to investigate the mechanisms behind semaglutide's cardiovascular protection.

Wegovy and Zepbound are undergoing testing to evaluate their benefits in various medical conditions such as reducing heart attack risk, treating sleep apnea, and managing kidney disease.

More For You

11th UK Gatka Championship

All winners received medals and trophies

UK Parliament

11th UK Gatka Championship ends with Welsh debut and £1,000 support for Gatka Akharas

Highlights:

  • The 11th UK National Gatka Championship was hosted near Cardiff, marking the first time in Wales.
  • Winners included Roop Kaur (girls), Navjot Singh (boys), and Gurdeep Singh (men’s).
  • Gatka Federation UK awarded £1,000 to each participating Akhara to support martial arts promotion.
  • Chief guests included MP Tanmanjeet Singh Dhesi and Harjeet Singh Grewal, President of the World Gatka Federation.

Gatka Championship marks Welsh debut

The 11th UK National Gatka Championship concluded on a high note near Cardiff, Wales, showcasing the traditional Sikh martial art with flair. Seven leading Gatka Akharas participated, thrilling spectators with their lightning-fast strikes, precision moves and elegant techniques.

Inauguration by global leaders

The tournament was inaugurated by Harjeet Singh Grewal, President of the World Gatka Federation (WGF) and the National Gatka Association of India (NGAI). He was joined by Tanmanjeet Singh Dhesi MP, President of Gatka Federation UK, alongside other dignitaries including Jagbir Singh Jagga Chakar, President of Wales Kabaddi Club, and community leaders from the Haveli Hotel Pontyclun.

Keep ReadingShow less
Vantara

The site, located in Gujarat, houses hundreds of elephants, as well as 50 bears, 160 tigers, 200 lions, 250 leopards, and 900 crocodiles. (Photo: Instagram/Vantara)

India court probe clears Ambani family’s animal centre

AN INDIAN Supreme Court-ordered investigation has cleared a large private animal facility run by the son of Asia’s richest man, rejecting allegations of wildlife violations.

Vantara, described as the “world’s biggest wild animal rescue centre,” is operated by Anant Ambani, son of Reliance Industries chairman Mukesh Ambani.

Keep ReadingShow less
Starmer

Starmer, who has faced negative coverage since taking office in July 2024, defended the appointment process.

Reuters

Starmer: I would not have appointed Mandelson if aware of Epstein ties

PRIME MINISTER Keir Starmer said on Monday he would not have appointed Peter Mandelson as UK ambassador to Washington had he known the extent of his links with convicted sex offender Jeffrey Epstein.

This was Starmer’s first public statement since dismissing Mandelson last week. The prime minister is facing questions over his judgement, including from Labour MPs, after initially standing by Mandelson before removing him from the post.

Keep ReadingShow less
Trump

Trump said the suspect had been arrested earlier for 'terrible crimes,' including child sex abuse, grand theft auto and false imprisonment, but was released under the Biden administration because Cuba refused to take him back.

Getty Images

Trump says accused in Dallas motel beheading will face first-degree murder charge

US PRESIDENT Donald Trump has described Chandra Mouli “Bob” Nagamallaiah, the Indian-origin motel manager killed in Dallas, as a “well-respected person” and said the accused will face a first-degree murder charge.

Nagamallaiah, 50, was killed last week at the Downtown Suites motel by co-worker Yordanis Cobos-Martinez, a 37-year-old undocumented Cuban immigrant with a criminal history.

Keep ReadingShow less
Starmer Mandelson

Starmer talks with Mandelson during a welcome reception at the ambassador's residence on February 26, 2025 in Washington, DC.

Getty

Starmer under pressure from party MPs after Mandelson dismissal

PRIME MINISTER Keir Starmer is facing questions within the Labour party after the sacking of US ambassador Peter Mandelson.

Mandelson was removed last week after Bloomberg published emails showing messages of support he sent following Jeffrey Epstein’s conviction for sex offences. The dismissal comes just ahead of US president Donald Trump’s state visit.

Keep ReadingShow less